#WorldCancerDay | When time matters, waiting is not an option.
Researchers at #MRCWIMM have developed a readily available immunotherapy approach that showed promise against difficult to treat childhood #leukaemia in early stage #research. 🧪
#ChildhoodCancer #CancerResearch
Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for in...